These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24861988)

  • 1. Ultrasound assessment of the diaphragm: Preliminary study of a canine model of X-linked myotubular myopathy.
    Sarwal A; Cartwright MS; Walker FO; Mitchell E; Buj-Bello A; Beggs AH; Childers MK
    Muscle Nerve; 2014 Oct; 50(4):607-9. PubMed ID: 24861988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
    Elverman M; Goddard MA; Mack D; Snyder JM; Lawlor MW; Meng H; Beggs AH; Buj-Bello A; Poulard K; Marsh AP; Grange RW; Kelly VE; Childers MK
    Muscle Nerve; 2017 Nov; 56(5):943-953. PubMed ID: 28370029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.
    Childers MK; Joubert R; Poulard K; Moal C; Grange RW; Doering JA; Lawlor MW; Rider BE; Jamet T; Danièle N; Martin S; Rivière C; Soker T; Hammer C; Van Wittenberghe L; Lockard M; Guan X; Goddard M; Mitchell E; Barber J; Williams JK; Mack DL; Furth ME; Vignaud A; Masurier C; Mavilio F; Moullier P; Beggs AH; Buj-Bello A
    Sci Transl Med; 2014 Jan; 6(220):220ra10. PubMed ID: 24452262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle function in a canine model of X-linked myotubular myopathy.
    Grange RW; Doering J; Mitchell E; Holder MN; Guan X; Goddard M; Tegeler C; Beggs AH; Childers MK
    Muscle Nerve; 2012 Oct; 46(4):588-91. PubMed ID: 22987702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gait characteristics in a canine model of X-linked myotubular myopathy.
    Goddard MA; Burlingame E; Beggs AH; Buj-Bello A; Childers MK; Marsh AP; Kelly VE
    J Neurol Sci; 2014 Nov; 346(1-2):221-6. PubMed ID: 25281397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical phenotype of X-linked myotubular myopathy in Labrador Retriever puppies.
    Snead EC; Taylor SM; van der Kooij M; Cosford K; Beggs AH; Shelton GD
    J Vet Intern Med; 2015 Jan; 29(1):254-60. PubMed ID: 25581576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons.
    Lawlor MW; Beggs AH; Buj-Bello A; Childers MK; Dowling JJ; James ES; Meng H; Moore SA; Prasad S; Schoser B; Sewry CA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):102-10. PubMed ID: 26823526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing clinical end points of respiratory function in large animals for clinical translation.
    Goddard MA; Mitchell EL; Smith BK; Childers MK
    Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):75-94, xi. PubMed ID: 22239876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.
    Beggs AH; Böhm J; Snead E; Kozlowski M; Maurer M; Minor K; Childers MK; Taylor SM; Hitte C; Mickelson JR; Guo LT; Mizisin AP; Buj-Bello A; Tiret L; Laporte J; Shelton GD
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14697-702. PubMed ID: 20682747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy.
    Snyder JM; Meisner A; Mack D; Goddard M; Coulter IT; Grange R; Childers MK
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):131-7. PubMed ID: 26086764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy.
    Dupont JB; Guo J; Renaud-Gabardos E; Poulard K; Latournerie V; Lawlor MW; Grange RW; Gray JT; Buj-Bello A; Childers MK; Mack DL
    Mol Ther; 2020 Feb; 28(2):382-393. PubMed ID: 31784415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.
    Karolczak S; Deshwar AR; Aristegui E; Kamath BM; Lawlor MW; Andreoletti G; Volpatti J; Ellis JL; Yin C; Dowling JJ
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked myotubular myopathy in a family with two infant siblings: a case with MTM1 mutation.
    Jeon JH; Namgung R; Park MS; Park KI; Lee C; Lee JS; Kim SH
    Yonsei Med J; 2011 May; 52(3):547-50. PubMed ID: 21488203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System.
    Souza PVS; Haselkorn T; Baima J; Oliveira RW; Hernández F; Birck MG; França MC
    Orphanet J Rare Dis; 2024 May; 19(1):188. PubMed ID: 38715109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of a mouse model of X-linked myotubular myopathy.
    Sarikaya E; Sabha N; Volpatti J; Pannia E; Maani N; Gonorazky HD; Celik A; Liang Y; Onofre-Oliveira P; Dowling JJ
    Dis Model Mech; 2022 Jul; 15(7):. PubMed ID: 35694952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.
    Andreoletti G; Romano O; Chou HJ; Sefid-Dashti MJ; Grilli A; Chen C; Lakshman N; Purushothaman P; Varfaj F; Mavilio F; Bicciato S; Urbinati F
    Am J Hum Genet; 2023 Oct; 110(10):1648-1660. PubMed ID: 37673065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.